1Fraur RN. Etiologic mechanisms in diabetic retinopathy. In: Ryan Sj. Retina, ed. 3. St Louis: Mosby,2001.1279-1285.
2Hammes HP, AIt A,Niwa T, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia, 1999,42:728-736.
3Handa JT, Verzijl N, Matsunaga H, et al. Increase in the advanced glycation and product pentosidine in Bruch' s membrane with age. Invest Ophtalmol Vis Sci, 1999,40(3) :775-779.
4Stitt AW. Advanced glycation:an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol,2001,85:746-753.
5Bloomgarden ZY. International Diabetes Federation Meeting. 1997. Diabetes Care, 1998,21(9) : 1560-1566.
6Endo M, Yanagisawa K, Tsuchida K, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res,2001,33:317-322.
7Stitt AW, Burke GA, Chen F, et al. Advanced glycation end-product receptor interact on microvascular cells within careolin-rich membrane domains. FASEB J,2000,14:2390-2392.
8Murata T, Nagai R, lshibashi T, et al. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diagetologia,1997,40:764-769.
9Treins C, Peraldi SG, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation and products. J Biol Chem, 2001,276(47) : 43836-43841.
10Lu M, Kuroki, Amano S, et al. Advanced glycation end products increase retinal vascular endothelial gowth factor expression. J Clin Invest, 1998,101 (6) : 1219-1224.
